HESTERBIO

Hester Biosciences Share PriceHester Biosciences

₹1699.00
21.1 (1.26%)
  • Advice
  • Hold
As on 22 March, 2023 | 03:16 BSE: 524669 NSE: HESTERBIO

Hester Biosciences Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in Hester Biosciences

Start SIP

Hester Biosciences Share Price

  • Over 1 Month -3.17%
  • Over 3 Month -6.91%
  • Over 6 Month -15.56%
  • Over 1 Year -30.71%

Hester Biosciences Key Statistics

P/E Ratio 48.5
PEG Ratio -1.7
Market Cap Cr 1,445
Price to Book Ratio 5.4
EPS 46.3
Dividend 0.6
Relative Strength Index 46.66
Money Flow Index 19.69
MACD Signal -27.5
Average True Range 65.22

Hester Biosciences Investment Rating

  • Master Rating:
  • Hester Biosciences has an operating revenue of Rs. 255.26 Cr. on a trailing 12-month basis. An annual revenue growth of 14% is good, Pre-tax margin of 23% is great, ROE of 15% is good. The company has a debt to equity of 63%, which is bit higher. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 57 which is a POOR score indicating inconsistency in earnings, a RS Rating of 32 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at E which indicates heavy supply, Group Rank of 67 indicates it belongs to a poor industry group of Medical-Ethical Drugs and a Master Score of C is fair but needs to improve. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Hester Biosciences Financials
IndicatorDec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 71725150
Operating Expenses Qtr Cr 52564140
Operating Profit Qtr Cr 1916910
Depreciation Qtr Cr 2223
Interest Qtr Cr 3211
Tax Qtr Cr 4422
Net Profit Qtr Cr 111055

Hester Biosciences Technicals

EMA & SMA

Current Price
₹1699.
21.1 (1.26%)
  • Bullish Moving Average
  • ___
  • 5
  • Bearish Moving Average
  • ___
  • 11
  • 20 Day
  • 1716.4
  • 50 Day
  • 1762.05
  • 100 Day
  • 1833.08
  • 200 Day
  • 1958.55
  • 20 Day
  • 1726.59
  • 50 Day
  • 1764.55
  • 100 Day
  • 1823.26
  • 200 Day
  • 1984.23

Hester Biosciences Resistance and Support

PIVOT
₹1688.29
Resistance
First Resistance 1715.27
Second Resistance 1752.64
Third Resistance 1779.62
RSI 46.66
MFI 19.7
MACD Single Line -27.5
MACD -29.78
Support
First Resistance 1650.92
Second Resistance 1623.94
Third Resistance 1586.57

Hester Biosciences Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 2,351 135,606 57.68
Week 5,777 389,125 67.36
1 Month 9,038 536,377 59.35
6 Month 7,098 288,520 40.65

Hester Biosciences Result Highlights

Hester Biosciences Synopsis

NSE-Medical-Ethical Drugs

Hester Biosciences L is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 219.35 Cr. and Equity Capital is Rs. 8.51 Cr. for the Year ended 31/03/2022. Hester Biosciences Ltd. is a Public Limited Listed company incorporated on 29/04/1987 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L99999GJ1987PLC022333 and registration number is 022333.
Market Cap 1,449
Sales 244
Shares in Float 0.39
No of funds 18
Yield 0.6
Book Value 5.38
U/D Vol ratio 0.6
LTDebt / Equity 27
Alpha -0.13
Beta 0.4

Hester Biosciences

Owner NameDec-22Sep-22Jun-22Mar-22
Promoters 53.73%53.73%53.73%
Mutual Funds 0.03%0.03%0.03%
Foreign Portfolio Investors 0.45%0.62%0.72%
Financial Institutions/ Banks
Individual Investors 32.96%32.74%32.61%
Others 12.83%12.88%12.91%

Hester Biosciences Management

Name Designation
Dr. Bhupendra Gandhi Chairman
Mr. Rajiv Gandhi Managing Director & CEO
Ms. Priya Gandhi Executive Director
Mr. Ravin Gandhi Director
Mr. Sanjiv Gandhi Director
Mr. Ashok Bhadakal Independent Director
Mr. Naman Patel Independent Director
Mr. Amit Shukla Independent Director
Mr. Sandhya Patel Independent Director
Mr. Ameet Desai Independent Director
Ms. Nina Gandhi Alternate Director

Hester Biosciences Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Hester Biosciences MF Shareholding

Name Amount(cr)
ITI Pharma and Healthcare Fund Regular Growth 134
Motilal Oswal S&P BSE Healthcare ETF 6

Hester Biosciences FAQs

What is Share Price of Hester Biosciences ?

Hester Biosciences share price is ₹1699 As on 22 March, 2023 | 03:02

What is the Market Cap of Hester Biosciences ?

The Market Cap of Hester Biosciences is ₹1445.3 Cr As on 22 March, 2023 | 03:02

What is the P/E ratio of Hester Biosciences ?

The P/E ratio of Hester Biosciences is 48.5 As on 22 March, 2023 | 03:02

What is the PB ratio of Hester Biosciences ?

The PB ratio of Hester Biosciences is 5.4 As on 22 March, 2023 | 03:02

Q2FY23

Start Investing Now!

Open Free Demat Account in 5 mins

Enter Valid Mobile Number